Trace level analysis of leached Protein A in bioprocess samples without interference from the large excess of rhMAb IgG.

J Immunol Methods

Analytical Operations, Process Research and Development, Genentech, Inc. 1 DNA Way, South San Francisco, CA 94080, United States.

Published: February 2009

AI Article Synopsis

  • Resins with Staphylococcal Protein A (PA) are used to purify recombinant human monoclonal antibodies, necessitating a sensitive assay to detect PA impurities.
  • The traditional ELISA method for measuring PA is hindered by the formation of a PA/IgG complex; however, a new multi-product PA ELISA method uses heating with detergents and chelators to dissociate the complex for accurate testing.
  • This innovative approach utilizes microwave technology for quick heating and high throughput, making it applicable to various rhMAb IgGs and enabling easier automation for the assay.

Article Abstract

Resins containing immobilized Staphylococcal Protein A (PA) are widely used in the commercial purification of recombinant human monoclonal antibody (rhuMAb IgG) biotherapeutics. Therefore, a sensitive assay for leached PA is needed to ensure that PA is not present at unacceptable levels as an impurity in the final product. PA impurities are measured by an ELISA using chicken anti-PA antibodies. However, PA in the presence of IgG product forms a PA/IgG complex that interferes in the assay. In this report a multi-product PA ELISA is described, wherein the PA/IgG complex is dissociated by heating in the presence of detergents and chelators prior to the ELISA. The dissociation facilitates the accessibility of the anti-PA antibodies to bind to PA in the immunoassay. Heat is provided by a novel microwave technology which allows brief heating time and high sample throughput using a microtiter plate for sample heating. Thus, broadly applicable dissociation conditions, suitable for all 21 rhMab IgGs tested to date were identified. This approach streamlines the measurement of leached PA, allows higher sample testing throughput, facilitates application across multiple products, and facilitates assay automation. Data comparing in-process samples tested with both the former product-specific ELISA and this new multi-product assay are shown.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jim.2008.10.015DOI Listing

Publication Analysis

Top Keywords

anti-pa antibodies
8
pa/igg complex
8
trace level
4
level analysis
4
analysis leached
4
leached protein
4
protein bioprocess
4
bioprocess samples
4
samples interference
4
interference large
4

Similar Publications

Bacillus cereus biovar anthracis (Bcbva) causes anthrax-like disease in animals, particularly in the non-human primates and great apes of West and Central Africa. Genomic analyses revealed Bcbva as a member of the B. cereus species that carries two plasmids, pBCXO1 and pBCXO2, which have high sequence homology to the B.

View Article and Find Full Text PDF

Anthrax Vaccination, Gulf War Illness, and Human Leukocyte Antigen (HLA).

Vaccines (Basel)

June 2024

The GWI and HLA Research Groups, Brain Sciences Center, Department of Veterans Affairs Health Care System, Minneapolis, MN 55417, USA.

We report on a highly significant, positive association between anthrax vaccination and occurrence of Gulf War Illness (GWI) in 111 Gulf War veterans (42 with GWI and 69 controls). GWI was diagnosed in 47.1% of vaccinated veterans but only in 17.

View Article and Find Full Text PDF

Development of a nano-emulsion based multivalent protein subunit vaccine against .

Front Immunol

May 2024

Department of Veterinary Pathobiology, Center for Veterinary Medicine, University of Missouri, Columbia, MO, United States.

(Pa) is an opportunistic bacterial pathogen responsible for severe hospital acquired infections in immunocompromised and elderly individuals. Emergence of increasingly drug resistant strains and the absence of a broad-spectrum prophylactic vaccine against both T3SA (type III secretion apparatus) and ExlA/T3SA Pa strains worsen the situation in a post-pandemic world. Thus, we formulated a candidate subunit vaccine (called ExlA/L-PaF/BECC/ME) against both Pa types.

View Article and Find Full Text PDF

(PA) is an opportunistic, frequently multidrug-resistant pathogen that can cause severe infections in hospitalized patients. Antibodies against the PA virulence factor, PcrV, protect from death and disease in a variety of animal models. However, clinical trials of PcrV-binding antibody-based products have thus far failed to demonstrate benefit.

View Article and Find Full Text PDF

Rapid and cost-effective epitope mapping using PURE ribosome display coupled with next-generation sequencing and bioinformatics.

J Biosci Bioeng

April 2024

Laboratory of Molecular Biotechnology, Graduate School of Bioagricultural Sciences, Nagoya University, Furo-cho, Chikusa-ku, Nagoya 464-8601, Japan. Electronic address:

A novel, efficient and cost-effective approach for epitope identification of an antibody has been developed using a ribosome display platform. This platform, known as PURE ribosome display, utilizes an Escherichia coli-based reconstituted cell-free protein synthesis system (PURE system). It stabilizes the mRNA-ribosome-peptide complex via a ribosome-arrest peptide sequence.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!